Kilitch Drugs (India) Ltd Share Price

₹337.40 5.40 (1.63%) BSE
as updated on 18-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:326.45
  • Day's High:339.20

  • 52 Week Low265.50
  • 52 Week High490.00

Kilitch Drugs (India) Ltd's key Fundamentals

Market Cap ₹590 Cr.
P/E Ratio 18.6
TTM EPS 18.2
P/B Ratio 1.87
ROE 10.35
Debt to Equity 0.19
Face Value 10
BVPS 180.7
3 Year Sales Growth 19.97%

Kilitch Drugs (India) Ltd's Share Price Returns

1 Day 1.63%
1 Week -1.30%
1 Month -5.10%
3 Months -5.10%
6 Months -21.60%
1 Years 8.50%
3 Years 113.40%
5 Years 264.60%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Kilitch Drugs (India) Ltd Shareholding Pattern

Promoters

(63.77%)

Institutions

(0.00%)

Non-Institutions

(36.23%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Kilitch Drugs (India) Ltd

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.

Kilitch is one of the largest manufacturers of antibacterial parenteral formulations. It is also one of the largest producers of sterile liquid formulations in small volumes in India. Kilitch also boasts of 25 years of quality contract manufacturing service to reputed national and multinational pharmaceutical companies. its sound knowledge about the industry has resulted in the growth of the organizations along with them as a leading contract manufacturing company in the country.

Keeping pace with the increasing demand of its clients for contract manufacturing, Kilitch has added 2 dedicated blocks and is in the process of adding another 3 dedicated fully USFDA / UKMHRA compliant manufacturing facility in Paonta Sahib (North India). All its plants are approved by the local as well as World Health Organization (WHO) for GMP standards. Kilitch has 3 manufacturing facilities spread across India.

Kilitch has over 25 years of experience in product development and manufacturing. It offers a wide spectrum of contract services, providing reliable supply, scientific expertise and bottom line results to meet the development, clinical and commercial outsourcing needs. Kilitch has been engaged in successful tie-ups with over 20 leading pharmaceutical companies -- Ranbaxy Laboratories Limited, Sandoz India Limited, Zydus Cadila, Nicholas Piramal India Limited, USV Limited, Merck Limited to name a few.

In 2010 the company listed its Equity Shares at NSE.

DCGI Approval-- The company has received the DCGI approvals for Ceftriaxone+Tazobactam, Ceftriaxone+Salbactam,Cefipime +Tazobactam and awaiting for approval for the following products, Rabeprazole, Ceftazidime+Tazobactam, Cefoperazone+Tazobactam

Product range of the company includes- Carbapenems, Cephalosporins, Beta - Lactam Antibiotics, Steroids & Hormones, Gastrology, Gastrology, NSAIDs, Anti Malarials

Kilitch has signed an agreement with a US-based pharmaceutical company for manufacturing of its generic molecules for the period of 2 year which started in mid 2008 and would like to expand their business thereon.

Clientele: Sandoz, Ranbaxy, Emcure, Nicholas, Ajanta pharma, Zuventas, Zydus Cadilla, USV, Flamingo Pharma and many others.

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 326.45
  • Day's High: 339.20

  • 52 Week Low265.50
  • 52 Week High490.00

Kilitch Drugs (India) Ltd's key Fundamentals

Market Cap ₹590 Cr.
P/E Ratio 18.6
TTM EPS 18.2
P/B Ratio 1.87
ROE 10.35
Debt to Equity 0.19
Face Value 10
BVPS 180.7
3 Year Sales Growth 19.97%

Kilitch Drugs (India) Ltd's Share Price Returns

1 Day 1.63%
1 Week -1.30%
1 Month -5.10%
3 Months -5.10%
6 Months -21.60%
1 Years 8.50%
3 Years 113.40%
5 Years 264.60%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×